한빛사논문 | BRIC

이재련 님의 논문 목록

울산대학교 의과대학

Glutathione dynamics is a potential predictive and therapeutic trait for neoadjuvant chemotherapy response in bladder cancer
- Cell Rep. Med., October 04, 2023 | https://doi.org/10.1016/j.xcrm.2023.101224
- 2023-10
- 의약학
- 한빛사논문
Enfortumab vedotin-related pneumonitis is more common than expected and could lead to acute respiratory failure
- Eur. J. Cancer, Volume 174, October 2022, Pages 81-89 | https://doi.org/10.1016/j.ejca.2022.07.014
- 2022-10
- 의약학
- 한빛사논문
A randomised phase II study of modified FOLFIRI.3 vs modified FOLFOX as second-line therapy in patients with gemcitabine-refractory advanced pancreatic cancer
- Br. J. Cancer, Volume 101, Issue 10, November 2009, Pages 1658-1663 | https://doi.org/10.1038/sj.bjc.6605374
- 2009-11
- 의약학
- 상위피인용논문
A single institutional phase III trial of preoperative chemotherapy with hyperfractionation radiotherapy plus surgery versus surgery alone for resectable esophageal squamous cell carcinoma
- Ann. Oncol., 15 (6): 947-954, June 2004, doi: 10.1093/annonc/mdh219
- 2004-06
- 의약학
- 상위피인용논문
- 이재련(울산의과대학교)
Multicenter phase II study of sunitinib in patients with non-clear cell renal cell carcinoma
- Ann. Oncol., First published online: January 6, 2012 | doi: 10.1093/annonc/mdr586
- 2012-01
- 의약학
- 구.추천논문

저자논문